Boots gender pay gap data is 5%, less than a third of national average

Boots gender pay gap data is 5%, less than a third of national average

March 26 2018 Boots has published data on its gender pay gap, indicating the pay gap benefits...

Prescription levy to rise to £8.80 from April 1 in England

Prescription levy to rise to £8.80 from April 1 in England

February 28 2018 The single NHS prescription charge will increase 20p to £8.80 per item...

Minister admits less than half of Pharmacy Integration Fund has been spent

Minister admits less than half of Pharmacy Integration Fund has been spent

December 19 2017 There has been a “significant underspend” of funding committed to...

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

September 20 2017 The Scottish Government has confirmed that £1 million will be available...

  • Boots gender pay gap data is 5%, less than a third of national average

    Boots gender pay gap data is 5%, less than a third of national average

    Monday, 26 March 2018 12:43
  • Prescription levy to rise to £8.80 from April 1 in England

    Prescription levy to rise to £8.80 from April 1 in England

    Wednesday, 28 February 2018 19:20
  • Minister admits less than half of Pharmacy Integration Fund has been spent

    Minister admits less than half of Pharmacy Integration Fund has been spent

    Tuesday, 19 December 2017 09:45
  • £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    Wednesday, 20 September 2017 14:00

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

prescription bagsApril 13 2016

Prescriptions dispensed in the community cost £9.27 billion in 2015, a 4.68% increase on the £8.85 billion cost in 2014.

The percentage increase in cost outpaced the increase in prescription numbers, up 1.79% from 1.06 billion in 2014 to 1.08 billion in 2015.

The prescription cost analysis for England for 2015 published by the Health and Social Care Information Centre provides details of the number of items and the net ingredient cost of all prescriptions dispensed in the community in England.

The most commonly prescribed drug was simvastatin with 34.4 million items, followed by omeprazole (30.1 million items), levothyroxine sodium (29.7 million), aspirin (28.0 million) atorvastatin (27.2 million), ramipril (26.7 million), amlodipine (25.4 million), lansoprazole (22.9 million), paracetamol (22.9 million) and salbutamol (21.9 million).

In terms of the most expensive net ingredient cost (NIC) per drug, fluticasone proprionate inhalers had NIC of £376.0 million for 7.8 million items, followed by pregabalin at £283.0 million for 4.8 million items, enteral nutrion at £266.7 million for 5.3 million items, budesonide at £197.0 million for 4.3 million items, and tiotropium at £194.1 million for 4.9 million items.

Among the top 20 most commonly prescribed items, metformin hydrochloride had the highest NIC cost, at £120.4 million for 19.8 million items, followed by levothyroxine at £104.5 million, co-codamol at £97.5 million for 15.7 million items and colecalciferol at £90.6 million for 19.9 million items

Glucose blood testing reagents had the highest NIC for non-medicines at £180.3 million for 6.8 million items.

“Further analysis of the PCA and Dental data will be published later in the year in the Prescriptions Dispensed in the Community publication,” said HSCIC.

Links:

HSCIC announcement

HSCIC: ‘Prescription Cost Analysis - England 2015 - Prescription items dispensed in the community in England and listed alphabetically within chemical entity by therapeutic class’

Finance News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...